Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
AKRIKHIN

July 2026

AKRIKHIN Market Share Analysis for July 2026

«Акрихин» – ведущая российская фармацевтическая компания, производящая эффективные, доступные по цене и высококачественные лекарственные препараты с 1936 года.
Year Founded1936
Employees1001 - 5000
Annual Revenue$500M - $1B
akrikhin.ru
AKRIKHIN
AKRIKHIN (including company regionals)
  • akrikhin.ru
    akrikhin.ru
See more website traffic and engagement information

AKRIKHIN Revenue up to July 2026 is 500M - 1B

revenue generated by AKRIKHIN top domains

AKRIKHIN top domains revenue over 3 years

Revenue for AKRIKHIN top domains


Total visits to AKRIKHIN's top domains

Understand AKRIKHIN market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in AKRIKHIN's top domains

Analyze AKRIKHIN engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on AKRIKHIN's top domains

See how AKRIKHIN keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by AKRIKHIN

These are the website technologies, by industry, used by AKRIKHIN top domains

Payment & Currencies (23)

PayPal

PayPal

Advertising (6)

DoubleClick

DoubleClick

Social (5)

Instagram

Instagram

Widget (3)

reCAPTCHA

reCAPTCHA

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from AKRIKHIN

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBinnopharm Group is planning to acquire Akrikhin.The Russian drugmaker Binnopharm Group, which was founded by the local billionaire Vladimir Yevtushenkov, hopes to acquire Akrikhin, the local drugmaker, which is owned by the Polish-Dutch company Polpharma and which produces some important and best selling drugs in the Russian market.

See all AKRIKHIN signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.